跳至主要内容
临床试验/NL-OMON47283
NL-OMON47283
已完成
3 期

The IMAGE1 S* Non-Muscle-Invasive bladder cancer study: A multicenter international randomized controlled study to compare the outcome using the IMAGE1 S* System versus White Light Imaging (WLI) during TURB of Non-Muscle-Invasive Bladder Cancer (NMIBC). - IMAGE1 S* bladder cancer study

Academisch Medisch Centrum0 个研究点目标入组 100 人待定

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Academisch Medisch Centrum
入组人数
100
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

入排标准

入选标准

  • Patients scheduled for treatment of a primary or recurrent NMIBC
  • Patients aged 18 years or older
  • Has or has had no tumors in the upper urinary tract
  • Has had no previous irradiation of the pelvis

排除标准

  • Gross haematuria at the time of TURB (i.e. heavy bladder bleeding resulting in marked amounts of blood in the urine which may interfere with cystoscopy)
  • Pregnancy or breast\-feeding (all women of child\-bearing potential must document a negative serum or urine pregnancy test at screening and are suggested to use the contraceptive pill or an intrauterine device (IUD) during the treatments and for at least one months thereafter)
  • Has had instillation therapy in the six months prior to the screening visit

结局指标

主要结局

未指定

相似试验

进行中(未招募)
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
进行中(未招募)
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
已完成
2 期
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladder
DRKS00003324Sanochemia Pharmazeutika AG227
已完成
不适用
Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.muscle invasive bladder cancermuscle invasive bladder carcinoma1003836410004994
NL-OMON45144Erasmus MC, Universitair Medisch Centrum Rotterdam320
招募中
不适用
Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.
NL-OMON23413Erasmus MC260